Novozymes is the world leader in bioinnovation, producing a wide range of industrial enzymes, microorganisms, and biopharmaceutical ingredients.
28. February 2013
Reduction of the company’s share capital by cancellation of a part of its holding of treasury B shares. The company’s B share capital is reduced by DKK 10,600,000 from DKK 542,512,800 to DKK 531,912,800.
22. February 2013
In reference to company announcement no. 4 of January 31, 2013, the closing conditions for the transaction have been met, and the acquisition of the enzymes business of Iogen Corporation by Novozymes has been completed.
11. June 2013
10. June 2013
| Copyright © 2010 Novozymes. All Rights Reserved.